Content Status
Type
Linked Node
TB Comorbidity Committee
Learning ObjectivesTerm of Reference (ToR) and agenda for the TB-comorbidity committee, stakeholders and operations.
H5Content
Content
In order to ensure screening for comorbidity, appropriate management of comorbidity and periodic clinical review of TB patients a coordination mechanism is essential. Adapting the learnings from the TB-HIV collaborative framework, the National Strategic Plan (NSP) 2017-2025 recommended the setting up of the National TB Comorbidity Coordination Committee to address various comorbidities affecting the TB treatment. Subsequently, the State and District TB comorbidity Coordination Committees (DTCCs) were established.
Terms of Reference (ToR) and Agenda for the TB Comorbidity Committee (TCC)
- To strengthen joint planning, recording, reporting and monitoring, and review activities between National TB Elimination Programme (NTEP) and the other programmes at the national, state and district levels
- To review and adopt policies for strengthening the implementation of joint TB–comorbidity activities
- To suggest strategies for roll-out and scale-up of activities aimed at minimising mortality and morbidity associated with TB and respective comorbidities
- To provide guidance for the implementation of joint TB–comorbidity activities and identify key areas for strengthening
- To support supervision and planning of TB–comorbidity activities, including joint field visits, joint monitoring, joint reviews, etc.
- To facilitate operational research to improve programme implementation and assess the impact of joint TB–comorbidity activities
- To support the development of normative tools and training material for TB and the comorbidities
- To review, optimise and plan for future collaborative activities between NTEP and the other comorbidity programmes
- To develop and share Information, Education, Communication (IEC) prototype with states/ UTs
Operation and Stakeholders of TCCs
|
TCC |
Meeting Frequency |
Stakeholders |
| National | Biannual | Deputy Director General TB (DDG TB, Head) and DDG's of all other comorbidity programmes, Addl. DDG TB and other programmes, World Health Organisation (WHO) representatives from TB and the comorbidity programmes, Representatives from national TB institutes, Experts from academic and research institutions, Representatives from civil society organisations, Programme managers, and TB patients. |
| State | Quarterly | Managing Director National Health Mission (NHM-Head), State TB Officer (STO), State nodal officers for the comorbidity programmes, Research and academic experts in TB and comorbidities, representatives from civil society organisations, programme officers from state cells, and TB patients. |
| District | Quarterly | District Collector-NHM (Head), District TB Officer, District Nodal Officers for the comorbidity programmes, Experts from research and academic institutes, Representatives from civil societies, professional bodies, and TB patients. |
Resources
- Guidelines on Programmatic Management of Drug-resistant TB (PMDT) in India, CTD, MoHFW, India, 2021.
- National Framework For Joint HIV/TB Collaborative Activities, NACO and CTD, MoHFW, India, 2009.
- National framework for joint TB-Diabetes collaborative activities, NPCDCS and NTEP, MoHFW, India, 2017
- National Framework for Joint TB-Tobacco Collaborative Activities, NTCP and NTEP, MoHFW, India, 2017.
Assessment
| Question | Answer 1 | Answer 2 | Answer 3 | Answer 4 | Correct answer | Correct explanation | Page id | Part of Pre-test | Part of Post-test |
| The TB Comorbidity Committee should review and adopt policies for strengthening the implementation of joint TB–comorbidity activities. | True | False | 1 | The TB Comorbidity Committee should review and adopt policies for strengthening the implementation of joint TB–comorbidity activities. | Yes | Yes |
Page Tags
LMS Page Link
Content Creator
Reviewer
Target Audience
- Log in to post comments